Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Pamphilon

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
British Journal of Haematology|March 23, 1999
Infections in adults undergoing unrelated donor bone marrow transplantationE C Williamson, M R Millar, C G Steward, et al.
Transfusion Medicine (Oxford, England)|March 1, 1997
A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactionsN A Anderson, S Gray, J A Copplestone, et al.
British Journal of Haematology|August 29, 1998
The outcome of children requiring admission to an intensive care unit following bone marrow transplantationC Hayes, R J Lush, J M Cornish, et al.
Bone Marrow Transplantation|January 11, 2000
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantationA J McCarthy, H M Kingman, C Kelly, et al.
Transfusion|April 1, 1996
A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancyE L Blundell, D H Pamphilon, I D Fraser, et al.
Bone Marrow Transplantation|June 22, 2005
Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletionR J Garland, S J Groves, P Diamanti, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Vox Sanguinis|April 28, 2009
New cellular therapies: is there a role for transfusion services?H W Reesink, S Panzer, M Dettke, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
British Journal of Haematology|March 23, 1999
Infections in adults undergoing unrelated donor bone marrow transplantationE C Williamson, M R Millar, C G Steward, et al.
Transfusion Medicine (Oxford, England)|March 1, 1997
A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactionsN A Anderson, S Gray, J A Copplestone, et al.
British Journal of Haematology|August 29, 1998
The outcome of children requiring admission to an intensive care unit following bone marrow transplantationC Hayes, R J Lush, J M Cornish, et al.
Bone Marrow Transplantation|January 11, 2000
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantationA J McCarthy, H M Kingman, C Kelly, et al.
Transfusion|April 1, 1996
A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancyE L Blundell, D H Pamphilon, I D Fraser, et al.
Bone Marrow Transplantation|June 22, 2005
Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletionR J Garland, S J Groves, P Diamanti, et al.
British Journal of Haematology|August 29, 1998
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Blood|December 3, 1998
Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemiaC J Knechtli, N J Goulden, J P Hancock, et al.
Vox Sanguinis|April 28, 2009
New cellular therapies: is there a role for transfusion services?H W Reesink, S Panzer, M Dettke, et al.
Pageof 8